• By ICR Secretariat
  • Posted Tuesday, November 1, 2022

ICR’s new study tracks disease progression in children with rare type of cancer

https://www.pharmatimes.com/news/icrs_new_study_tracks_disease_progression_in_children_with_rare_type_of_cancer_1478307

Blood tests could help guide the treatment of children with the cancer rhabdomyosarcoma (RMS), according to a new study led by scientists at the Institute of Cancer Research, London (ICR).